Needham Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $58
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsInitiationPrice Target
Needham analyst Mike Matson initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $58.
Needham analyst Mike Matson initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $58.